Pennsylvania Lawmakers Weigh Rules for Natural and Synthetic Kratom

Why it matters

Pennsylvania proposals would affect which kratom products can be sold, who can buy them, and how retailers are held accountable. The reporting also highlights the limited surveillance data available to clinicians and policymakers.

The big picture

Pennsylvania is considering approaches that distinguish natural leaf products from synthetic and highly concentrated products. The debate follows federal emergency scheduling of three synthetic compounds and recent state actions elsewhere.

Key findings

• Pennsylvania lawmakers are considering bills that would prohibit synthetic kratom products and set standards for natural products.
• The proposals discussed would limit natural-product sales to people age 21 and older.
• The bills would require product labeling and standards, while placing liability on sellers rather than criminalizing possession or use.
• Pennsylvania reported 17 overdose deaths with kratom as a contributing factor in 2026 through the article’s reporting period; the article notes that deaths may involve other substances.
• State poison-control reports cited in the story rose from 114 in 2025 to 106 through June 30, 2026, including 41 involving 7-OH.

What they say

RAND researcher Laura Nettuno told the Capital-Star: “The regulation is evolving very quickly. Products and producers are responding to that very, very quickly.”

Bottom line

**Pennsylvania’s emerging proposals focus on product standards, age limits, and synthetic derivatives while important questions about use and risk remain unresolved.**